To improve the IRB review process and strengthen institutional oversight of TFDA approval status for human trials, TMU-JIRB has completed an enhancement to the TMU-eJIRB system with the new feature “TFDA Submission Status Management,” which is now officially launched.

Key Features:

1. Applicants (Principal Investigators, Study Coordinators/Assistants, Co- Investigators/Sub-Investigators, and Sponsors) may upload TFDA approval documents directly to the system.
2. For human trial applications requiring TFDA approval, if such approval has not yet been obtained, only a copy of the IRB approval letter will be available for download.

For detailed information and instructions, please refer to the User Manual.

If you have any questions, please contact us at tmujirb@gmail.com or call (02) 6620-2589 ext. 15313.